“Golden Ticket” award for HEPHAISTOS from Amgen France and BioLabs Hôtel-Dieu
December 10th, 2024
HEPHAISTOS-Pharma has the honor to be a winner of a Golden Ticket from Amgen France x BioLabs Hôtel-Dieu in Paris.
We have won one year of free residency at BioLabs Hôtel-Dieu and personalized mentorship from Amgen experts to accelerate the development of our innovative project and create synergies.
We would like to thank the jury members for their time, expertise and feedback. Their contributions are very useful for us to understand the pharmaceutical needs and to define the clinical strategy:
- Nathalie Varoqueaux MD PhD, Executive Medical Director, Amgen
- Marie MORICE-MORAND, Associate Director of Innovation & Digital, Amgen
- Mads Nørregaard-Madsen, Scientific Director, Amgen R&D Copenhagen
- Martha S. Head, Executive Director, Computational & Data Sciences, Amgen
- Matthias Klinger, Director Research, Amgen Research Gmbh, Germany
- Margalit Haber, Ph.D., Business Development Manager, R&D Transformation, Strategy & Opera-tions, Precision Medicine, Amgen
- Gilles Gnacadja, PhD, Executive Director Data Sciences & Engineering, Technology Innovation Lab, Amgen
- Matthew Foster, DBA, Executive Director Technology Strategy & Innovation, Technology Innovation Lab, Amgen
- Saad Shah, Director Technology Strategy & Innovation, Digital & AI solutions, Technology Innovation Lab, Amgen
- Dihya Benhamouche, Innovation Project Manager, Amgen
Special thanks to the BioLabs France Team for welcoming us and organizing the event Christophe Tallec and Johanna Michielin.
